Table 5.
Significantly enriched GO terms in the largest component of I∃0.8
| Category | ID | Description | p-value | Adjusted p-value (FDR) | Count | Total |
|---|---|---|---|---|---|---|
| MF | GO:0044822 | poly(A) RNA binding | 4.37E-12 | 1.35E-09 | 50 | 1180 |
| CC | GO:0005654 | nucleoplasm | 1.93E-09 | 6.54E-08 | 63 | 1745 |
| CC | GO:0070062 | extracellular vesicular exosome | 2.39E-09 | 7.09E-08 | 59 | 1589 |
| BP | GO:0006915 | apoptotic process | 1.32E-07 | 1.20E-05 | 49 | 1305 |
| BP | GO:0016567 | protein ubiquitination | 1.75E-07 | 1.52E-05 | 28 | 542 |
| CC | GO:0005730 | nucleolus | 5.61E-06 | 1.06E-04 | 38 | 1072 |
| CC | GO:0031226 | intrinsic component of plasma membrane | 1.66E-05 | 2.89E-04 | 49 | 1612 |
| BP | GO:0006366 | transcription from RNA polymerase II promoter | 1.60E-05 | 6.57E-04 | 26 | 611 |
| CC | GO:0005887 | integral component of plasma membrane | 5.07E-05 | 8.34E-04 | 46 | 1546 |
| BP | GO:0071156 | regulation of cell cycle arrest | 2.62E-05 | 9.70E-04 | 10 | 116 |
| BP | GO:0001775 | cell activation | 5.63E-05 | 1.86E-03 | 31 | 856 |
| BP | GO:0045087 | innate immune response | 7.46E-05 | 2.34E-03 | 34 | 993 |
| CC | GO:0000228 | nuclear chromosome | 1.60E-04 | 2.43E-03 | 19 | 453 |
| MF | GO:0042803 | protein homodimerization activity | 4.87E-05 | 3.26E-03 | 26 | 781 |
| MF | GO:0019901 | protein kinase binding | 4.93E-05 | 3.26E-03 | 22 | 603 |
| MF | GO:0008201 | heparin binding | 5.51E-05 | 3.40E-03 | 11 | 182 |
| BP | GO:0071901 | negative regulation of protein serine/threonine kinase activity | 1.29E-04 | 3.69E-03 | 10 | 140 |
| BP | GO:0007596 | blood coagulation | 1.36E-04 | 3.80E-03 | 22 | 541 |
| CC | GO:0005783 | endoplasmic reticulum | 3.16E-04 | 4.27E-03 | 51 | 1918 |
| BP | GO:0051222 | positive regulation of protein transport | 1.88E-04 | 4.88E-03 | 15 | 301 |
| BP | GO:0000086 | G2/M transition of mitotic cell cycle | 2.27E-04 | 5.70E-03 | 10 | 150 |